ClinicalTrials.govpublic full text
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
b cell lymphoma, sscart-19, relapsed or refractory b-cell lymphma, il-6, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856100
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.